Effect of Alternating Postures on Cognitive Performance
NCT02863731, Not applicable, Completed, University of Applied Sciences Upper Austria
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Alternating Postures on Cognitive Performance | ClinicalTrials.gov |
| NCT number | NCT02863731 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 46 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Applied Sciences Upper Austria | ClinicalTrials.gov |
| Conditions | Sedentary Lifestyle | ClinicalTrials.gov |
| Interventions | Alternating working postures, first day, Alternating working postures, second day | ClinicalTrials.gov |
| First posted | 2016-08-11 | ClinicalTrials.gov |
| Last updated | 2016-08-17 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Reaction time | 2 experimental days | Reaction time is a commonly measured parameter to describe mental states, fatigue or performance in ergonomic research. As the effect of alternating postures on reaction time is still unclear, a digital version of the Color-Word-Conflict-Stroop-Test has been implemented. It contained 190 congruent, incongruent and neutral tasks and required approximately 10 min to simulate long-lasting monotonous office screen work. The reaction time was measured and recorded automatically. Outliers (values outside of the limits of 3 standard deviations) have been automatically eliminated. The Stroop-Test is characterized by a high test-retest reliability. Due to the cross-over design of the study two days were necessary to determine the interventional effect. According to the group allocation the participants executed the Stroop-test either in an alternating or sitting posture. Differences in reaction time and accuracy between "alternating" and "sitting" days will be analyzed. | ClinicalTrials.gov |
| Primary | Attentional performance | 2 experimental days | As the effect of alternating postures on attentional performance is still unclear, an attentional performance test called "d2R-test of attention" has been implemented. The d2R-test was executed as a pen and paper version. Therefore, it enabled screen breaks during the test protocol and simulated paper-related office work. The d2R-Test is characterized by a high test-retest reliability and do not require any specific previous knowledge except of rudimentary language skills. Normative values for the d2R-test are available for different countries. Attentional performance and accuracy were manually determined according to the d2R-guidelines. Due to the cross-over design of the study two days were necessary to determine the interventional effect. According to the group allocation the participants executed the d2R-test either in an alternating or sitting posture. Differences in attentional performance and accuracy between "alternating" and "sitting" days will be analyzed. | ClinicalTrials.gov |
| Primary | Working speed | 2 experimental days | Physical efforts when performing standardized tests (e.g. standing or walking) can negatively influence cognitive parameters as well as working speed. To determine the effect of alternating postures on working speed a digital text editing task encouraging participants to fill in spaces in an ergonomic guideline text for 10 min was used. Working speed (words per minute) and accuracy (relative error) have been manually calculated. Due to the cross-over design of the study two days were necessary to determine the interventional effect. According to the group allocation the participants executed the text editing task either in an alternating or sitting posture. Differences in working speed between "alternating" and "sitting" days will be analyzed. | ClinicalTrials.gov |
| Primary | Workload perception | 2 experimental days | Sit-to-stand workstations can evoke positive as well as negative associations. A common method to rate workload perception is the NASA-TLX questionnaire (Task Load Index, National Aeronautics and Space Administration). For reasons of simplicity and unmodified sensitivity, the short version of this questionnaire (RTLX, raw task load index), consisting of six major items, was used. Influences on workload perception based on unweighted items in the RTLX were negated due to the cross-over design. Due to the cross-over design of the study two days were necessary to determine the interventional effect. According to the group allocation the participants scored their perceived workload after executing several cognitive tests in an alternating or sitting posture. Differences in workload perception between "alternating" and "sitting" days will be analyzed. | ClinicalTrials.gov |
| Other | Body movements | 2 experimental days | Body movements can alter physiological parameters and cognitive performance. Especially small movements during longer time intervals are very hard to classify by means of personal observations. Therefore, a three-dimensional accelerometer - placed on the sternum via a neoprene breast belt - was used to objectively measure body movements. Upper body placements of accelerometers have been shown to reliably detect body movements, and sit-to-stand as well as stand-to-sit transitions. To reduce the total number of sensors, a HRV-recorder with integrated 3D-accelerometer was used. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 10
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)